Plasma Protease C1-inhibitor Treatment Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Hereditary Angioedema (HAE)

 

Plasma Protease C1-inhibitor Treatment Market

The plasma protease C1-inhibitor treatment market comprises therapies such as C1 esterase inhibitor and plasma-derived C1-inhibitor concentrate. These therapies are used to treat hereditary angioedema (HAE), which is caused due to C1-inhibitor deficiency or dysfunction. The global prevalence of HAE is estimated to be 1 in 50,000 people. HAE leads to acute and painful swelling of various body parts including limbs, face, gastrointestinal tract and throat. Timely and adequate treatment plays a crucial role in preventing permanent organ damage and even mortality in some cases. The demand for effective therapeutic options for treating HAE has been increasing globally.


The Global plasma protease C1-inhibitor Treatment Market Demand is estimated to be valued at US$ 6257.99 Bn in 2024 and is expected to exhibit a CAGR of 6.7% over the forecast period 2024 to 2030.


Key Takeaways

Key players operating in the plasma protease C1-inhibitor treatment are R&D. Koninklijke Philips N.V., Panasonic Corporation, and Procter & Gamble are among the major participants. Koninklijke Philips N.V. offers C1-inhibitor therapy such as Cinryze in over 45 countries for prophylaxis treatment against HAE attacks.

The key opportunities in the market include growing awareness about HAE diagnosis and treatment options. Various awareness campaigns by patient advocacy groups and pharmaceutical companies are helping increase recognition about HAE among physicians as well as general public.

Globally, the demand for plasma protease C1-inhibitor treatment therapies is expanding beyond developed regional markets. The growth is driven by increasing healthcare investments, infrastructure development and rising disposable incomes in emerging nations. Manufacturers are focusing on expanding their distribution network and launching affordable biosimilar products in high growth potential markets such as Asia Pacific, Latin America, Middle East and Africa.

Market drivers: The increasing FDA approvals of novel therapies is a major market driver. For instance, in 2021, the FDA approved Takhzyro (lanadelumab-flyo) injection for routine prevention of recurrent hereditary angioedema (HAE) attacks in patients 12 years and older.

Market restrain: High costs of therapy remains a key challenge in the market. The annual cost of plasma C1-inhibitor treatment ranges between US$ 100,000 to US$ 200,000 limiting widespread adoption. However, emergence of affordable biosimilar drugs could help address this challenge over the forecast period.


Segment Analysis

The plasma protease C1-inhibitor treatment market is dominated by hereditary angioedema segment. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling (edema) of the hands, feet, limbs, genitals, face, bowel wall and throat. Attacks in the throat area can lead to airway blockage and death by asphyxiation if not treated. This segment holds majority share due to rapidly rising prevalence of HAE globally and high costs of medication required for its treatment. Recurrent spontaneous attacks are common and severely impact quality of life for HAE patients.

Global Analysis

North America is currently the fastest growing and dominating regional market for plasma protease C1-inhibitor treatment and is expected to continue its dominance over the forecast period. Majority of key players are headquartered in the region and have strong distribution channels across countries. The US dominates the North American as well as global market owing to high healthcare expenditure, strong reimbursement policies, and rising awareness among physicians and patients regarding available treatment options for HAE. Regulatory approvals for new drug candidates are also relatively faster in the US compared to other regions. However, Asia Pacific region will witness highest growth during the forecast period due to rising healthcare infrastructure, disposable incomes, and patient population base in countries such as China and India.

Get more insights on this topic: Plasma Protease C1-inhibitor Treatment Market

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The increasing demand for adhesives and sealants is anticipated to open up the new avenue for Petroleum Resins Market

Image
Petroleum Resins Market  Market Overview: Petroleum resins are amorphous thermoplastic polymers made from petroleum-based feedstock materials, through either thermal or catalytic polymerization. They are mainly used for applications such as adhesives, inks, paints, rubber compounding, and others. Different types of petroleum resins include C5 resins, C9 resins, hydrogenated hydrocarbons (HHCs), and modified and specialized petroleum resins. Among applications, adhesives and sealants hold the largest share in the petroleum resins market owing to increasing use of petroleum resins in hot melt and pressure sensitive adhesives. Market Dynamics: The increasing demand for adhesives from packaging and construction industries is a major driver for the petroleum resins market. According to statsista, the global adhesive market was valued at over US$ 53.3 billion in 2020 and is projected to reach around US$ 78 billion by 2027, growing at a CAGR of over 5.7% during the forecast period. Pe...
Read more

Global Synthetic Biology Market Analysis: Size and Share

Image
Synthetic Biology Market  Synthetic biology encompasses the design, construction, and redesigning of biological parts, devices, and systems, either non-existent in nature or reengineered from existing biological systems. The market is experiencing significant growth, driven by the increasing demand for personalized medicine and healthcare. Applications of synthetic biology span pharmaceuticals, chemical production, agriculture, environmental protection, and renewable energy. Advancements in synthetic biology contribute to the rapid manufacturing of biotherapeutics, fostering the development of personalized medicine and more cost-effective healthcare solutions. The Synthetic Biology Market is projected to be valued at US$ 31,693.59 million in 2023, with an expected CAGR of 28% during the forecast period from 2023 to 2030, according to a newly published report by Coherent Market Insights. Key Market Trends: A prominent trend in the Global Synthetic Biology Market is the escalat...
Read more